<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The transcription factor FOXC2 plays a key role in adipocyte differentiation and the FOXC2 gene is a candidate gene for Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether the FOXC2 -512C&gt;T promoter variant is associated with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or its intermediary phenotypes in <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant subjects </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The variant was genotyped using PCR-RFLP in 705 unrelated Type 2 diabetic patients, 505 unrelated <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant control subjects and 219 glucose-tolerant offspring of Type 2 diabetic probands </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The frequency of the T-allele was 58% (95% CI 56-61%) and 59% (56-62%) among the Type 2 diabetic patients and the unrelated <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant control subjects, respectively ( p=0.6) </plain></SENT>
<SENT sid="4" pm="."><plain>Among the <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant subjects, the T-allele carriers had higher fasting serum <z:chebi fb="0" ids="17855">triglyceride</z:chebi> ( p=0.03), fasting serum C-<z:chebi fb="7" ids="16670">peptide</z:chebi> concentrations ( p=0.009) and insulinogenic index ( p=0.04) </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, in <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant women, the waist-to-hip ratio was significantly higher in carriers of the T-allele </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION/INTERPRETATION: Our data suggest that the FOXC2 -512C&gt;T variant is not associated with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>However, among <z:chebi fb="105" ids="17234">glucose</z:chebi>-tolerant subjects the variant is associated with hypertriglyceridaemia and increased fasting serum C-<z:chebi fb="7" ids="16670">peptide</z:chebi> </plain></SENT>
</text></document>